Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

SHA:603718 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	353.23	358.5	140.74	156.55	153.04	18.01
Trading Asset Securities	162.59	158.58	212.48	236.15	385.59	502.73
Cash & Short-Term Investments	515.82	517.08	353.22	392.71	538.63	520.74
Cash Growth	60.85%	46.39%	-10.06%	-27.09%	3.44%	-12.52%
Accounts Receivable	105.46	108.97	84.95	97.41	89.95	59.92
Other Receivables	2.81	2.92	4.91	7.67	31.43	4.83
Receivables	108.28	111.89	89.86	105.08	121.37	64.75
Inventory	61.75	55.01	102.82	144.89	142.62	115.95
Other Current Assets	5.09	7.79	16.65	22.36	172.82	41.06
Total Current Assets	690.94	691.77	562.55	665.03	975.44	742.49
Property, Plant & Equipment	58.37	60.6	164.6	219.45	275.9	434.57
Long-Term Investments	-	-	639.09	315.32	224.7	233.23
Goodwill	1,020	1,006	225.33	224.14	224.14	224.14
Other Intangible Assets	54.23	55.58	38.1	73.56	100.23	109.43
Long-Term Deferred Tax Assets	0.73	0.74	18.6	12.45	8.46	7.93
Long-Term Deferred Charges	16.85	5.92	9.16	3.34	5.32	4.9
Other Long-Term Assets	2.54	6.52	0.3	0.96	29.91	30.05
Total Assets	1,843	1,827	1,658	1,514	1,844	1,787
Accounts Payable	8.9	6.79	28.56	42.29	39.43	24.24
Accrued Expenses	21.01	25.13	9.52	23.08	32.83	8.2
Short-Term Debt	-	-	270.19	133.39	473.04	466.91
Current Portion of Leases	3.04	3.66	0.83	9.86	2.01	-
Current Income Taxes Payable	2.65	8.76	4.99	24.73	7.81	5.21
Current Unearned Revenue	7.15	9.81	21.61	15.46	32.63	34.59
Other Current Liabilities	37.37	46.09	81.34	71.94	82.22	100.85
Total Current Liabilities	80.12	100.25	417.04	320.75	669.96	640.01
Long-Term Leases	12.58	13.94	-	14.87	2.62	-
Long-Term Unearned Revenue	-	-	64.45	66.26	182.19	183.43
Long-Term Deferred Tax Liabilities	8.89	9.46	1.47	1.37	2.12	1.11
Total Liabilities	101.6	123.65	482.96	403.25	856.9	824.54
Common Stock	655.66	657.9	657.9	644	644	644
Additional Paid-In Capital	276.38	281.86	229.69	139.86	131.57	136.62
Retained Earnings	681.34	663.1	398.41	372.05	250.44	274.93
Treasury Stock	-31.75	-42.38	-66.44	-	-	-
Comprehensive Income & Other	-	-	-2.57	-15.57	-20.41	2.78
Total Common Equity	1,582	1,560	1,217	1,140	1,006	1,058
Minority Interest	160.09	142.72	-42.19	-29.33	-18.41	-96.13
Shareholders' Equity	1,742	1,703	1,175	1,111	987.19	962.2
Total Liabilities & Equity	1,843	1,827	1,658	1,514	1,844	1,787
Total Debt	15.62	17.6	271.02	158.12	477.66	466.91
Net Cash (Debt)	500.2	499.49	82.2	234.59	60.97	53.82
Net Cash Growth	472.41%	507.66%	-64.96%	284.77%	13.27%	-67.87%
Net Cash Per Share	0.76	0.76	0.13	0.37	0.09	0.06
Filing Date Shares Outstanding	655.66	655.66	657.9	644	644	644
Total Common Shares Outstanding	655.66	657.9	657.9	644	644	644
Working Capital	610.82	591.53	145.51	344.28	305.48	102.48
Book Value Per Share	2.41	2.37	1.85	1.77	1.56	1.64
Tangible Book Value	507.75	499.19	953.55	842.63	681.23	724.76
Tangible Book Value Per Share	0.77	0.76	1.45	1.31	1.06	1.13
Buildings	23.4	23.4	168.06	166.12	289.13	366.9
Machinery	56.68	42.64	157.38	179.48	231.62	293.63
Construction In Progress	2.66	12.72	0.75	5.24	2.94	59.69

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.